Lomustine Capsule
NDC Package 80005-116-02
Package Information
Lomustine capsules is a medication used to treat various types of cancer. This formulation utilizes a capsule delivery system. Marketed by Carnegie Pharmaceuticals Llc, this product is identified by NDC 80005-116 and is authorized under FDA application ANDA219265.
Identification & Billing
- RxCUI: 197894 - lomustine 10 MG Oral Capsule
- RxCUI: 197895 - lomustine 100 MG Oral Capsule
- RxCUI: 197896 - lomustine 40 MG Oral Capsule
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 80005 - Carnegie Pharmaceuticals Llc
- 80005-116 - Lomustine
- 80005-116-02 - 5 CAPSULE in 1 BOTTLE
- 80005-116 - Lomustine
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 80005-116-02 identifies a specific commercial package of 5 capsule in 1 bottle of Lomustine, a human prescription drug labeled by Carnegie Pharmaceuticals Llc. This product is billed for "EA" each discreet unit and contains an estimated amount of 5 billable units per package. This capsule is formulated for oral use and contains lomustine as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Carnegie Pharmaceuticals Llc on November 10, 2025. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat various types of cancer. Lomustine belongs to a class of drugs known as alkylating agents. It works by slowing or stopping the growth of cancer cells.
How is this Carnegie Pharmaceuticals Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 80005011602. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.